Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
OVERTON et al v. SANOFI-AVENTIS U.S., LLC
Case Number:
3:13-cv-05535
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Sectors & Industries:
-
September 04, 2015
Sanofi Pays $2.4M To Kill Cancer Drug Sales Class Action
Sanofi-Aventis US LLC has agreed to pay $2.4 million to employees who alleged the pharmaceutical giant shorted them commission payments from sales of the cancer drug Zaltrap, according to a preliminary settlement filed Friday in federal court in New Jersey
-
September 19, 2013
Sanofi Accused Of Shorting Staff For Sales Of Cancer Drug
Two former Sanofi-Aventis US LLC sales employees hit the pharmaceutical giant with a putative class action Tuesday, claiming the company backtracked on commission agreements stemming from sales of the cancer drug Zaltrap.